Literature DB >> 7577996

Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine.

P F Neuenschwander1, E Bianco-Fisher, A R Rezaie, J H Morrissey.   

Abstract

The effect of phosphatidylethanolamine (PE) on the activity of the factor VIIa-tissue factor complex (fVIIa-TF) has been examined with respect to plasma clotting activity and activation of factor X (fX) in a purified system. Vesicles prepared by relipidating membrane-anchored TF (dcTF; TF1-244, lacking the C-terminal cytoplasmic tail) into phospholipid vesicles containing 6 mol % phosphatidylserine (PS) and increasing levels of PE up to 40 mol % (the balance consisting of phosphatidylcholine) were found to progressively shorten TF-initiated clotting in normal human plasma to levels comparable to those observed using dcTF relipidated with cephalin. The shortened clotting times were at least in part due to the ability of PE-containing membranes to better support the activation of fX by the fVIIa.TF complex, as vesicles with increased PE content yielded progressively higher initial rates of fX activation. Surprisingly, PE substantially altered the sensitivity of fX activation to low levels of PS, yielding near-maximal rates of activation at only 3 mol % PS compared to 15-20 mol % PS required in the absence of PE. The effect of PE was not synergistic with that of PS since PE did not increase fX activation rates at high levels of PS (20 mol %). Examination of the kinetic parameters for fX activation revealed that the majority of the effect of PE was in decreasing the apparent Km for fX.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577996     DOI: 10.1021/bi00043a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.

Authors:  Lin Chen; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

Review 2.  Is testing for antiphosphatidylethanolamine antibodies clinically useful?

Authors:  Marielle Sanmarco
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

3.  Restoring full biological activity to the isolated ectodomain of an integral membrane protein.

Authors:  Emily K Waters; James H Morrissey
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

4.  Polyphosphate modulates blood coagulation and fibrinolysis.

Authors:  Stephanie A Smith; Nicola J Mutch; Deepak Baskar; Peter Rohloff; Roberto Docampo; James H Morrissey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

5.  The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.

Authors:  K Aupeix; B Hugel; T Martin; P Bischoff; H Lill; J L Pasquali; J M Freyssinet
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity.

Authors:  Eric Calvo; Daniella M Mizurini; Anderson Sá-Nunes; José M C Ribeiro; John F Andersen; Ben J Mans; Robson Q Monteiro; Michail Kotsyfakis; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

7.  Low-carb tissue factor?

Authors:  J H Morrissey
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

8.  Influence of membrane composition on the enhancement of factor VIIa/tissue factor activity by magnesium ions.

Authors:  Narjes Tavoosi; James H Morrissey
Journal:  Thromb Haemost       Date:  2013-11-28       Impact factor: 5.249

9.  Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.

Authors:  N J Mutch; E K Waters; J H Morrissey
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

Review 10.  Blood clotting reactions on nanoscale phospholipid bilayers.

Authors:  James H Morrissey; Vincent Pureza; Rebecca L Davis-Harrison; Stephen G Sligar; Y Zenmei Ohkubo; Emad Tajkhorshid
Journal:  Thromb Res       Date:  2008       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.